Hypolipidemia is associated with the severity of COVID-19
A study investigated pathological alteration in plasma lipid levels of COVID-19 patients. LDL-c and TC levels were significantly lower in COVID-19 patients as compared with normal subjects. Significant and gradual decreases in levels of LDL-c and TC were observed in all patients. HDL-c levels only decreased significantly in critical cases as compared with levels in […]
Treatment Tips as COVID-19 Complicates CVD Management in Diabetes
COVID-19 and related cardio-renal-pulmonary damage can profoundly affect the cardiovascular risk management of people with diabetes. It is recommended to continue ACE inhibitors and angiotensin receptor blockers, both SGLT2 inhibitors and GLP-1 receptor agonists have anti-inflammatory activities, which might be beneficial for patients with COVID-19. However, several expert groups in diabetes have previously advised that […]
Cardiovascular disease and COVID-19
Respiratory illness is the dominant clinical manifestation of COVID-19; CVD involvement occurs rarely. Acute cardiac injury, defined as a significant elevation of cardiac troponins, is the most commonly reported cardiac abnormality in COVID-19 affecting ~8–12% of patients. A Chinese study reported the incidence of heart failure in 52% of COVID-19 patients who subsequently died and […]
Multiple Sclerosis to Have Milder COVID-19 Symptoms?
A cross-sectional study conducted on 543 Multiple Sclerosis patients suggested that most Multiple Sclerosis patients developed a mild course of COVID-19 infection. The study was conducted to identify suspected COVID-19 cases and associated factors in Multiple Sclerosis patients by interrogation over phone and evaluating the medical records. Common symptoms suspicious for COVID-19 infection included dyspnea, […]